Kuros Biosciences Ltd. (KURN)
SIX Swiss Exchange · Health Technology
Compliant under the screens we randebt 1%, cash under 1%, limit 30%
Kuros Biosciences Ltd stock (KURN) is compliant with AAOIFI Shari'ah Standard No. 21 per our screen dated 2026-10-29: debt 1% and cash under 1% of the 12-month average market capitalisation against a 30% limit.
Purification shareunder 0.1%
Follow it in your portfolioFollow this stock on Telegram for free
- Price
- 19.90 CHFLast close 2026-10-27
- Market cap
- 751.86 M CHFat the 2026-10-27 close
- Symbol
- SIX:KURN
- Market
- SIX Swiss Exchange
- Sector
- Health Technology
- Industry
- Medical Specialties
Figures as of 2026-10-29 13:13
Sharia screening
Compliant under the screens we ran
We apply AAOIFI Shari'ah Standard No. 21, Financial Paper (Shares and Bonds), issued on 30 Rabi' I 1425 AH (20 May 2004), as published on AAOIFI's website. We last reviewed its limits on 2026-10-01. We read what the standard says; we do not issue fatwas.
This is an automated read of published screens, not a fatwa. We name what we ran; whatever we did not run stays outside the read.
Kuros Biosciences Ltd in numbers
Kuros Biosciences Ltd ranks 37 of 47 in the Health Technology sector on SIX Swiss Exchange by market cap (751.86 M CHF). Its debt-to-equity ratio is 0.15. The P/E is 112.
Published figures with their date, not financial advice. Market cap and P/E use the 2026-10-27 close.
The five screens, one by one
Sharia safety margin: 98 / 100 · Compliant, wide margin from the limits · Not applied: receivables · as of 2026-10-29
Sharia safety margin: 98 / 100 · Compliant, wide margin from the limits · Not applied: receivables · as of 2026-10-29
We ran 4 of 5 screens; the Sharia safety margin is 98 / 100.
| Business activity (sector and industry) | No excluded activity in its sector or industry | Passed |
| Interest-bearing debt to market cap | 1%, limit 30% | Passed |
| Cash and interest-bearing securities to market cap | under 1%, limit 30% | Passed |
| Non-permissible income to revenue | under 0.1%, limit 5% | Passed |
| Receivables to market cap | Not run: the standard sets no limit for it |
Purification share
under 0.1% of the company's revenue is non-permissible income, and the shareholder gives away that share of the stock's earnings. We show the share only; we do not publish a per-share amount.
Figures as of 2026-10-29 13:13
Company facts
- Debt-to-equity ratio 0.15
Figures computed from the company's published financial statements and read on 2026-10-29. They move with every new statement; this states a figure, it is an educational reading, not financial advice.
Fundamental filter
Meets the filter, with stated notes
- The company actually earned a profit over the last twelve months. Met
- Its debt does not exceed twice its shareholders' equity. Met
- The rest of the fundamental filter: every check in full, with its state — met, not met, or not measured.
- And whatever the source does not publish is named as such — never counted as a met check.
These are this page's items only; each plan's full list is on the pricing page.
Figures as of 2026-10-29
An automated quality screen on published figures, not financial advice. Every threshold is stated, every reason is named with its figure and its date, and the decision stays yours.
Today's model reading
The same four tools that read the daily report's markets, applied to this stock's completed bars.
- Today's call on this stock — up, down, or no call — and how many model votes stand behind it.
- All four tools one by one: cycles, historical analogue, seasonal pattern and momentum — each with its lean and its figure, and any tool that gave no read is named as such.
- Last completed close, average daily range, twenty-day range and the month band — shown when this stock has enough bars to compute them.
These are this page's items only; each plan's full list is on the pricing page.
Completed bars through 2026-10-27 · 5978 bars
Automated educational reading, not a recommendation. The decision is yours.
Frequently asked about Kuros Biosciences Ltd
What is the Sharia safety margin of Kuros Biosciences Ltd?
For Kuros Biosciences Ltd, Sharia safety margin: 98 / 100 · Compliant, wide margin from the limits · Not applied: receivables · as of 2026-10-29. The Sharia safety margin, out of 100, measures how far the debt and cash ratios sit from their stated limits; the five screens are broken down on the page.
Does Kuros Biosciences Ltd stock need purification?
under 0.1% of the company's revenue is non-permissible income, and the shareholder gives away that share of the stock's earnings. We show the share only; we do not publish a per-share amount.
How do I work out zakat on Kuros Biosciences Ltd shares?
The zakat calculator on this site gives an indicative amount from the value of the shares you hold; detailed rulings belong to scholars.
Which market lists Kuros Biosciences Ltd?
Kuros Biosciences Ltd is listed on SIX Swiss Exchange under the symbol KURN.
What the subscription adds
This page is open to everyone. Inside the subscription this stock also carries its composite score and its parts, valuation ratios, its share of its sector, a read of its financial statements, and following it from your account. None of them is financial advice.